BackTable Urology

In this episode of the BackTable Urology Podcast, Dr. Ashish Kamat discusses contemporary management of high-risk, non-muscle-invasive bladder cancer (NMIBC) and his thoughts into the future of this arena.---CHECK OUT OUR SPONSORSiemens Healthineers Theranosticshttps://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics---SYNPOSISDr. Kamat explores the evolving role of BCG and potential alternative therapies such as gemcitabine and docetaxel. He also covers effective clinical management, emerging clinical trials, and nuanced decision-making principles for radical cystectomy. Finally, the conversation touches on Dr. Kamat’s expert insights regarding the future of NMIBC management, including predictive biomarkers and personalized medicine.---TIMESTAMPS00:00 - Introduction03:56 - Initial Diagnosis and Workup12:22 - High-Grade Bladder Cancer22:37 - BCG and Alternative Treatments31:30 - BCG Unresponsive Disease36:56 - Novel Intravesical and Systemic Therapies46:45 - Future Directions---RESOURCESRelated BackTable episodes:https://www.backtable.com/shows/urology/podcasts/64/management-of-bcg-refractory-nmibchttps://www.backtable.com/shows/urology/podcasts/157/the-bladder-cancer-matters-podcasthttps://www.backtable.com/shows/urology/podcasts/103/adjuvant-therapy-for-high-risk-bladder-cancer

Dr. Charla Holdren, a resident at the University of Michigan-West, and Dr. Christine Van Horn, an endourology fellow at Loyola, explore the high rates of infertility and pregnancy complications among female urologists.---CHECK OUT OUR SPONSORFellowhttps://www.meetfellow.com/---SYNPOSISFirst, the two experts discuss personal experiences in family planning and challenges faced regularly in the hospital environment. They outline the complexities of assisted reproductive technology and offer insights for a better path forward, including cultural shifts, new policies, and supportive resources to better accommodate the needs of female surgeons.---TIMESTAMPS00:00 - Introduction04:05 - Dr. Holdren and Dr. Van Horn’s Journeys06:57 - Challenges in Family Planning17:51 - Parental Leave Policies26:56 - Advanced Reproductive Technology33:46 - Looking Towards the Future---RESOURCESFellowhttps://www.meetfellow.com/

As part of our recurring resident-focused series "PGY Playlist", guest hosts Dr. Lindsay Hampson (UCSF) and Dr. Gina Badalato (Columbia) speak with Onyi Ibeziako, a third-year resident at UT Southwestern, about effectively handling challenges during the early years of urology residency.---SYNPOSISDr. Ibeziako offers practical advice on managing competing responsibilities, building relationships with hospital staff, and developing early surgical skills. She offers valuable personal insights on self-directed study, triage of tasks, and making the most of these valuable years to set up for a successful career ahead.---TIMESTAMPS00:00 - Introduction05:43 - Early Residency Challenges10:51 - Relationships with Nursing14:23 - Multitasking24:06 - Developing Surgical Skills as an Intern33:09 - Continuous Learning and Final Pearls of Wisdom

In this episode of the BackTable Urology Podcast, Dr. Jose Silva and Dr. Spencer Hiller discuss holmium laser enucleation of the prostate (HoLEP), including preoperative and postoperative care, and the technical nuances of the procedure.---CHECK OUT OUR SPONSORSiemens Healthineers Theranosticshttps://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics---SYNPOSISDr. Hiller emphasizes the importance of patient education, bladder retraining, and the holistic management of incontinence. The conversation also touches on the science of lasers, effective morcellation, and practical challenges in achieving successful outcomes.---TIMESTAMPS00:00 - Introduction07:58 - HoLEP Patient Counseling21:29 - HoLEP Surgical Techniques33:54 - Morcellation: Challenges and Best Practices37:16 - Post-Operative Care47:21 - Postoperative Urinary Symptoms

Dr. Aditya Bagrodia sits down with Elie Toubiana, founder and CEO of ScribeMD.ai, to discuss the transformative potential of artificial intelligence (AI) in medical documentation.---SYNPOSISTheir conversation covers the capabilities and benefits of using an AI-driven medical scribe that ensures HIPAA compliance, reduces physician burnout, and enhances patient interactions. Elie also shares his insights about the technology’s adaptability across various medical fields. Finally, Dr. Bagrodia and Elie discuss ethical considerations surrounding applications of AI in other aspects of healthcare, such as medical workup and diagnosis.---TIMESTAMPS00:00 - Introduction06:00 - How ScribeMD AI Works14:14 - Integration with EMR20:31 - Legal Considerations with AI Technology26:34 - Cost Implications of AI Scribes38:46 - Future of AI in Medical Diagnosis41:45 - Conclusion and Final Thoughts---RESOURCESScribeMD.aihttps://www.scribemd.ai/

In this episode of the BackTable Urology, Dr. Bogdana Schmidt (University of Utah), Dr. Woodson Smelser (Washington University in St. Louis), and Dr. Jeff Tosoian (Vanderbilt University) discusses the latest insights and advancements in prostate and bladder cancer treatment presented at AUA 2024.---CHECK OUT OUR SPONSORVeracytehttps://www.veracyte.com/decipher---SYNPOSISFirst, the doctors cover noteworthy topics, including the effectiveness of early screening and treatment for high-risk prostate cancer patients, innovative approaches in imaging and biomarkers, and the impact of new guidelines on salvage therapy. They also explore emerging treatments for non-muscle invasive bladder cancer (NMIBC), as well as the evolving role of systemic immunotherapies and advanced genomic testing. To wrap up, the urologists offer detailed analyses and their expert opinions on how these developments could transform patient care in the field of urologic oncology.---TIMESTAMPS00:00 - Introductions03:06 - Prostate Cancer Screening Insights10:10 - Advancements in MRI and Biomarkers18:22 - Transperineal vs. Transrectal Prostate Biopsy27:18 - New Guidelines for Bladder Cancer Treatment30:57 - Innovative Drug Delivery Systems32:36 - Gene Therapy and Immunotherapy Advances40:11 - Concluding Thoughts and Future Prospects---RESOURCESDecipher Prostate Genomic Classifier by Veracyte:​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/

In this episode of Back Table Urology, Dr. Aditya Bagrodia, Dr. Joshua Langston, and Dr. Mara Holton from the Large Urology Group Practice Association (LUGPA) share insights on the financial and administrative complexities that urologists face.---CHECK OUT OUR SPONSORFellowhttps://www.meetfellow.com/---SYNPOSISThe doctors delve into the increasing costs of healthcare, the challenges posed by regulatory requirements, and the significance of physician leadership in influencing healthcare delivery. The discussion also highlights the importance of advocacy, the evolving role of physicians in business and policy, and actionable steps doctors can take to ensure their voices are heard. Finally, the doctors address the growing trend of hospital employment among physicians and its impact on rural healthcare access.---TIMESTAMPS00:00 - Introduction06:41 - Complexities and Costs in Healthcare11:48 - The Role of Physicians in Healthcare Leadership17:21 - The Shift Towards Hospital Employment27:35 - Economic Pressures on Physicians and Patients30:09 - Cost Discrepancies in Medical Procedures38:16 - Burnout and Workforce Challenges49:26 - Advocacy and Call to Action---RESOURCESFellowhttps://www.meetfellow.com/BackTable URO Ep. 82- Advocacy Basics for the Urologist: From Your Clinic to Capitol Hill with Dr. Ruchika Talwarhttps://open.spotify.com/episode/0hcLrKuf5QU7TZCHSErs4Z?si=842c7985f44c4e04BackTable URO Ep. 164: Urology Advocacy: From Passion to Policy with Dr. Seth Cohen, Dr. Michelle Leach, and Dr. Suzette Sutherlandhttps://open.spotify.com/episode/68pR7MxFIgQ1HJLy6xQHDX?si=36a93eedd6594770

In this episode of BackTable Urology, host Dr. Aditya Bagrodia, urologic oncologist Dr. Philippe Speiss (Moffitt Cancer Center), and medical oncologist Dr. Andrea Necchi (Università Vita-Salute San Raffaele) have an in-depth discussion about the mission and achievements of the Global Society of Rare Genitourinary Tumors (GSRGT).---CHECK OUT OUR SPONSORSSiemens Healthineers Theranosticshttps://www.siemens-healthineers.com/en-us/clinical-specialities/theranosticsVeracytehttps://www.veracyte.com/decipher---SYNPOSISFirst, the doctors discuss the society’s mission to improve the diagnosis and treatment of rare genitourinary cancers globally. They give an overview of their educational efforts, international collaborations, and significant achievements in clinical research. The discussion also covers the importance of global representation, the challenges of studying rare tumors, and future directions, such as leveraging artificial intelligence. The episode concludes with an emphasis on the society’s commitment to being inclusive and providing opportunities for young investigators.---TIMESTAMPS00:00 - Introduction06:45 - Origins and Missions of GSRGT11:21 - Challenges in Rare Cancer Research31:51 - Future Directions in Rare Cancer Treatment38:38 - How to Get Involved with GSRGT---RESOURCESSiemens Healthineers Theranostics:https://www.siemens-healthineers.com/en-us/clinical-specialities/theranosticsDecipher Prostate Genomic Classifier by Veracyte:​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/GSRGT Websitehttps://www.gsrgt.com/Andrea Necchi Websitehttps://www.andreanecchi.com/

In this episode, Dr. Matthew Cooperberg (UC San Francisco) and Dr. Arvin George (Johns Hopkins) join host Dr. Aditya Bagrodia in a conversation about guidelines and treatment algorithms for focal therapy in prostate cancer treatment.---CHECK OUT OUR SPONSORSSiemens Healthineers Theranosticshttps://www.siemens-healthineers.com/en-us/clinical-specialities/theranosticsVeracytehttps://www.veracyte.com/decipher---SYNPOSISFirst, the doctors discuss focal therapy in prostate cancer treatment from various perspectives, including the challenges of treating certain lesions, the comparison of different focal therapy modalities like high-intensity focused ultrasound (HIFU) and brachytherapy, cryotherapy and the importance of patient-specific factors in treatment decisions. They emphasize the need for clinical trials and registries to validate focal therapy outcomes, the potential expansion of indications for focal therapy, and the critical role of advanced imaging and genomic classifiers in patient selection and treatment planning. The discussion also touches on the potential of focal therapy to evolve as a standard care option alongside advancements in understanding the biology of prostate cancer and improving imaging and treatment technologies.---TIMESTAMPSSiemens Healthineers Theranostics:https://www.siemens-healthineers.com/en-us/clinical-specialities/theranosticsDecipher Prostate Genomic Classifier by Veracyte:​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/---RESOURCESSiemens Healthineers Theranostics:https://www.siemens-healthineers.com/en-us/clinical-specialities/theranosticsDecipher Prostate Genomic Classifier by Veracyte:​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/

In this episode of Backtable Urology Podcast, Ken Mitchell MPAS, PA-C, a certified physician associate, speaks about the role of interprofessional collaboration in treating male sexual dysfunction and infertility.---CHECK OUT OUR SPONSORKYZATREX™https://www.kyzatrex.com---SYNPOSISFirst, Ken highlights his journey into men’s health, sparked by the debut of erectile dysfunction medication and his engagement in vascular medicine. He then discusses how he leveraged his clinical background to address prevalent issues such as erectile dysfunction and testosterone management. Ken emphasizes the importance of education, collaboration, and innovative treatment approaches in providing effective patient care. Dr. Silva and Ken also cover the potential of oral testosterone treatments and their growing acceptance among patients due to convenience and cost-effectiveness. Ken shares insights into his role in advancing APP utilization in urology practices and ensuring comprehensive care coverage. Finally, Ken introduces his nonprofit organization, GUYnecology Men’s Health, an initiative aimed at fostering a broader understanding of preventative care among patients and healthcare professionals.---TIMESTAMPS00:00 - Introduction06:28 - Expanding the Role of APPs in Urology14:47 - Addressing Testosterone Replacement Therapy21:40 - Exploring Treatment and Insurance Challenges in Urology Practices27:35 - The Evolution of Oral Testosterone Treatments35:29 - Incorporating Telehealth and Enhancing Patient Education36:03 - Introducing Guynecology: A New Approach to Men’s Health41:44 - Final Thoughts and Advice for Urologists and APPs---RESOURCESKYZATREXhttps://www.kyzatrex.com/GUYnecology Men’s Health Associationhttps://learnguynecology.org/